John Dillman is the founder of VBI Vaccines (formerly SciVac Therapeutics). VBI Vaccines (formerly SciVac Therapeutics) has raised $381M in total funding.
John Dillman has been appointed as the Chief Commercial Officer of VBI Vaccines Inc. He was previously the Commercial Lead at Syneos Health for VBI, where he orchestrated commercial initiatives for the launch of PreHevbrio. Prior to Syneos Health, he spent 17 years at Sanofi Pasteur in various commercial leadership roles.
Full founder directory · Investor directory · Company funding database · Fundraising library